Taizhou, China

Weiwei Xu

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Shanghai Institute of Pharmaceutical Industry, Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiwei Xu. Retrieved from https://idiyas.com/inventor/weiwei-xu-wu87pb02

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Weiwei Xu - Pioneering Inventor from Taizhou

Introduction: Weiwei Xu is a highly accomplished inventor hailing from Taizhou, China. She is known for her groundbreaking innovations in various fields.

Latest Patents: Weiwei Xu holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes. Her most recent patents focus on eco-friendly packaging solutions and energy-efficient technologies.

Career Highlights: With a career spanning over two decades, Weiwei Xu has worked with leading research institutions and companies to develop cutting-edge technologies. She has received numerous awards for her contributions to the field of innovation.

Collaborations: Weiwei Xu has collaborated with top universities and multinational corporations to bring her inventions to the market. Her partnerships have led to the successful commercialization of several patented technologies.

Conclusion: Weiwei Xu's dedication to innovation and her passion for creating sustainable solutions have solidified her reputation as a trailblazing inventor in Taizhou and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…